Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Favorable outcomes of allogeneic hematopoietic stem cell transplantation with fludarabine-bendamustine conditioning and posttransplantation cyclophosphamide in classical Hodgkin lymphoma.
Beynarovich A, Lepik K, Mikhailova N, Borzenkova E, Volkov N, Moiseev I, Zalyalov Y, Kondakova E, Kozlov A, Stelmakh L, Pirogova O, Zubarovskaya L, Kulagin A, Afanasyev B. Beynarovich A, et al. Among authors: kondakova e. Int J Hematol. 2022 Sep;116(3):401-410. doi: 10.1007/s12185-022-03355-3. Epub 2022 May 5. Int J Hematol. 2022. PMID: 35511399
A Study of Safety and Efficacy of Nivolumab and Bendamustine (NB) in Patients With Relapsed/Refractory Hodgkin Lymphoma After Nivolumab Monotherapy Failure.
Lepik KV, Mikhailova NB, Kondakova EV, Zalyalov YR, Fedorova LV, Tsvetkova LA, Kotselyabina PV, Borzenkova ES, Babenko EV, Popova MO, Darskaya EI, Baykov VV, Moiseev IS, Afanasyev BV. Lepik KV, et al. Hemasphere. 2020 Jun 8;4(3):e401. doi: 10.1097/HS9.0000000000000401. eCollection 2020 Jun. Hemasphere. 2020. PMID: 32647803 Free PMC article.
A Phase 2 Study of Nivolumab Using a Fixed Dose of 40 mg (Nivo40) in Patients With Relapsed/Refractory Hodgkin Lymphoma.
Lepik KV, Fedorova LV, Kondakova EV, Zalyalov YR, Babenko EV, Lepik EE, Kotselyabina PV, Beynarovich AV, Popova MO, Volkov NP, Stelmakh LV, Baykov VV, Moiseev IS, Mikhailova NB, Kulagin AD, Afanasyev BV. Lepik KV, et al. Among authors: kondakova ev. Hemasphere. 2020 Sep 23;4(5):e480. doi: 10.1097/HS9.0000000000000480. eCollection 2020 Oct. Hemasphere. 2020. PMID: 33062947 Free PMC article.
[The first results of treatment for adult acute myeloid leukemia according to the AML-01.10 protocol of the Research Group of the Hematology Centers of Russia].
Parovichnikova EN, Kliasova GA, Sokolov AN, Troitskaia VV, Kokhno AV, Kuz'mina LA, Shaforostova II, Ryzhko VV, Kravchenko SK, Bondarenko SN, Lapin VA, Pristupa AS, Konstantinova TS, Zagoskina TP, Ialykomov IV, Moskov VI, Anchukova LV, Kaporskaia TS, Volodicheva EM, Kaplanov KD, Kondakova EV, Samoĭlova OS, Gavrilova LV, Kulikov SM, Savchenko VG. Parovichnikova EN, et al. Among authors: kondakova ev. Ter Arkh. 2012;84(7):10-5. Ter Arkh. 2012. PMID: 23038965 Clinical Trial. Russian.
[First results of Ph-negative acute lymphoblastic leukemia therapy of adults according to the protocol of Research Group of Russian Hematological Centers ALL-2009].
Parovichnikova EN, Kliasova GA, Isaev VG, Sokolov AN, Kokhno AV, Troitskaia VV, Mavrina EV, Khodunova EE, Ustinova EN, Gribanova EO, Kravchenko SK, Ryzhko VV, Kaporskaia TS, Baranova OIu, Bondarenkko SN, Nizametdinova AS, Kondakova EV, Ryl'tsova TV, Alufer'eva AN, Samoĭlova OS, Skamorina OP, Gavrilova LV, Pristupa AS, Vopilina NA, Konstantinova TS, Kriuchkova IV, Anchukova LV, Tikunova TS, Kaplanov KD, Lapin VA, Tumakov VA, Kozmina MN, Chernysh SA, Podol'tseva EI, Kulikov SM, Davidian IuR, Savchenko VG. Parovichnikova EN, et al. Among authors: kondakova ev. Ter Arkh. 2011;83(7):11-7. Ter Arkh. 2011. PMID: 21894746 Clinical Trial. Russian.
[Toxicity of different treatment protocols for acute myeloid leukemias in adults: the results of four Russian multicenter studies].
Parovichnikova EN, Savchenko VG, Kliasova GA, Isaev VG, Sokolov AN, Kulikov SM, Ustinova EN, Gribanova EO, Ryzhko VV, Khoroshko ND, Kravchenko SK, Galstian GM, Konstantinova TS, Zagoskina TP, Ziuzgin IS, Kaplanov KD, Moskov VI, Sokolova IV, Anchukova LV, Lapin VA, Loginov AB, Tumakov VA, Korobkin AV, Miliutina GI, Samoĭlova OS, Tikunova TS, Pristupa AS, Kondakova EV, Domnikova NP, Gavrilova LV, Obidina NA, Porokhina OV, Rekhtman GB, Mashchuk VN, Khuazheva NK, Kaporskaia TS, Golubeva ME, Maksimov AG, Ploskikh MA, Men'shakova SN, Mal'tsev VI, Rossiev VA, Pilipenko GI. Parovichnikova EN, et al. Among authors: kondakova ev. Ter Arkh. 2010;82(7):5-11. Ter Arkh. 2010. PMID: 20853602 Clinical Trial. Russian.
39 results